Stocktoria
Xylem Inc. XYL
Xylem Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0B | $8.6B | $7.4B | $5.5B | $5.2B | $4.9B | $5.2B | $5.2B | $4.7B | $3.8B |
| Gross profit | $3.5B | $3.2B | $2.7B | $2.1B | $2.0B | $1.8B | $2.0B | $2.0B | $1.8B | $1.5B |
| R&D expense | $226.0M | $230.0M | $232.0M | $206.0M | $204.0M | $187.0M | $191.0M | $189.0M | $181.0M | $110.0M |
| SG&A expense | $1.9B | $1.9B | $1.8B | $1.2B | $1.2B | $1.1B | $1.2B | $1.2B | $1.1B | $914.0M |
| Operating income | $1.2B | $1.0B | $652.0M | $622.0M | $585.0M | $367.0M | $486.0M | $654.0M | $552.0M | $408.0M |
| Interest expense | — | — | $49.0M | $50.0M | $76.0M | $77.0M | $67.0M | $82.0M | $82.0M | $70.0M |
| Income tax | $231.0M | $197.0M | $26.0M | $85.0M | $84.0M | $31.0M | $15.0M | $36.0M | $136.0M | $80.0M |
| Net income | $957.0M | $890.0M | $609.0M | $355.0M | $427.0M | $254.0M | $401.0M | $549.0M | $331.0M | $260.0M |
| EPS (diluted) | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 | $1.40 | $2.21 | $3.03 | $1.83 | $1.45 |
| Operating cash flow | $1.2B | $1.3B | $837.0M | $596.0M | $538.0M | $824.0M | $839.0M | $586.0M | $686.0M | $497.0M |
| Cash & equivalents | $1.5B | $1.1B | $1.0B | $944.0M | $1.3B | $1.9B | $724.0M | $296.0M | $414.0M | $308.0M |
| Inventory | $983.0M | $996.0M | $1.0B | $799.0M | $700.0M | $558.0M | $539.0M | $595.0M | $524.0M | $522.0M |
| Total assets | $17.6B | $16.5B | $16.1B | $8.0B | $8.3B | $8.8B | $7.7B | $7.2B | $6.9B | $6.5B |
| Total liabilities | $5.9B | $5.6B | $5.9B | $4.4B | $5.0B | $5.8B | $4.7B | $4.4B | $4.3B | $4.3B |
| Shareholders' equity | $11.5B | $10.6B | $10.2B | $3.5B | $3.2B | $3.0B | $3.0B | $2.8B | $2.5B | $2.2B |
Growth · year-over-year · Revenue CAGR 10.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +5.5% | +16.3% | +33.4% | +6.3% | +6.5% | -7.1% | +0.8% | +10.6% | +24.8% | +3.2% |
| Net income growth | +7.5% | +46.1% | +71.5% | -16.9% | +68.1% | -36.7% | -27.0% | +65.9% | +27.3% | -23.5% |
| EPS growth | +7.4% | +30.8% | +42.3% | -16.6% | +67.9% | -36.7% | -27.1% | +65.6% | +26.2% | -22.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.